Your browser doesn't support javascript.
loading
Tachykinins and the potential causal factors for post-COVID-19 condition.
Janket, Sok-Ja; Fraser, Douglas D; Baird, Alison E; Tamimi, Faleh; Sohaei, Dorsa; Conte, Harry A; Prassas, Ioannis; Diamandis, Eleftherios P.
Afiliação
  • Janket SJ; Center for Clinical and Translational Research, The Forsyth Institute, Cambridge, MA, USA.
  • Fraser DD; Paediatric Critical Care, Western University and Lawson Health Research Institute, London, ON, Canada.
  • Baird AE; Department of Neurology, SUNY Health Sciences University, Brooklyn, NY, USA.
  • Tamimi F; College of Dental Medicine, Qatar University, Doha, Qatar.
  • Sohaei D; McGill University School of Medicine, Montreal, QC, Canada.
  • Conte HA; Department of Infectious Diseases, Johnson Memorial Hospital, Stafford Springs, CT, USA.
  • Prassas I; Laboratory Medicine Program, University Health Network, Toronto, ON, Canada.
  • Diamandis EP; Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, ON, Canada. Electronic address: diamandis@lunenfeld.ca.
Lancet Microbe ; 4(8): e642-e650, 2023 08.
Article em En | MEDLINE | ID: mdl-37327802
ABSTRACT
The most prevalent symptoms of post-COVID-19 condition are pulmonary dysfunction, fatigue and muscle weakness, anxiety, anosmia, dysgeusia, headaches, difficulty in concentrating, sexual dysfunction, and digestive disturbances. Hence, neurological dysfunction and autonomic impairments predominate in post-COVID-19 condition. Tachykinins including the most studied substance P are neuropeptides expressed throughout the nervous and immune systems, and contribute to many physiopathological processes in the nervous, immune, gastrointestinal, respiratory, urogenital, and dermal systems and participate in inflammation, nociception, and cell proliferation. Substance P is a key molecule in neuroimmune crosstalk; immune cells near the peripheral nerve endings can send signals to the brain with cytokines, which highlights the important role of tachykinins in neuroimmune communication. We reviewed the evidence that relates the symptoms of post-COVID-19 condition to the functions of tachykinins and propose a putative pathogenic mechanism. The antagonism of tachykinins receptors can be a potential treatment target.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neuropeptídeos / COVID-19 Limite: Humans Idioma: En Revista: Lancet Microbe Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neuropeptídeos / COVID-19 Limite: Humans Idioma: En Revista: Lancet Microbe Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos